Cargando…
Enhancing diversity of clinical trial populations in multiple sclerosis
BACKGROUND: Demographic characteristics, social determinants of health (SDoH), health inequities, and health disparities substantially influence the general and disease-specific health outcomes of people with multiple sclerosis (MS). Participants in clinical trials do not represent all people with M...
Autores principales: | Marrie, Ruth Ann, Chataway, Jeremy, Bierer, Barbara E, Finlayson, Marcia, Martinez-Lapiscina, Elena H, Panagoulias, Jennifer, Sormani, Maria Pia, Williams, Mitzi Joi, Amezcua, Lilyana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413791/ https://www.ncbi.nlm.nih.gov/pubmed/37555490 http://dx.doi.org/10.1177/13524585231189677 |
Ejemplares similares
-
Assessing heterogeneity of treatment effect in multiple sclerosis trials
por: Sormani, Maria Pia, et al.
Publicado: (2023) -
Enhancing involvement of people with multiple sclerosis in clinical trial design
por: Gray, Emma, et al.
Publicado: (2023) -
Improving the efficiency of clinical trials in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023) -
Interface of Multiple Sclerosis, Depression, Vascular Disease, and Mortality: A Population-Based Matched Cohort Study
por: Palladino, Raffaele, et al.
Publicado: (2021) -
Management of vascular risk in people with multiple sclerosis at the
time of diagnosis in England: A population-based study
por: Palladino, Raffaele, et al.
Publicado: (2023)